Reduced activity of B lymphocytes, recognised by Sysmex XN-2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019
Open Access
- 1 February 2021
- journal article
- letter
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 43 (1) , E5-E8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort studyWorld Journal of Emergency Surgery, 2020
- Hospitalization and Mortality among Black Patients and White Patients with Covid-19New England Journal of Medicine, 2020
- COVID‐19 and the clinical hematology laboratoryInternational Journal of Laboratory Hematology, 2020
- Hematological findings and complications of COVID‐19American Journal of Hematology, 2020
- Hematologic parameters in patients with COVID‐19 infectionAmerican Journal of Hematology, 2020
- New parameters on the hematology analyzer XN‐10 (SysmexTM) allow to distinguish childhood bacterial and viral infectionsInternational Journal of Laboratory Hematology, 2016
- Sepsis affects most routine and cell population data (CPD) obtained using the Sysmex XN‐2000 blood cell analyzer: neutrophil‐related CPD NE‐SFL and NE‐WY provide useful information for detecting sepsisInternational Journal of Laboratory Hematology, 2014
- Sensitivity and specificity of the high fluorescent lymphocyte count-gate on the Sysmex XE-5000 hematology analyzer for detection of peripheral plasma cellsClinical Chemistry and Laboratory Medicine (CCLM), 2011
- Identification and quantification of high fluorescence‐stained lymphocytes as antibody synthesizing/secreting cells using the automated routine hematology analyzer XE‐2100Cytometry Part B: Clinical Cytometry, 2007